CSF1R and cancer: Third, although targeting CSF1R has shown as a novel therapeutic strategy for inflammatory, autoimmune disorders and cancer, such as rheumatoid arthritis and breast cancer, a direct association between CSF1R and HCC development has not been evidenced22,23.